Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron vs Solifenacin for Overactive Bladder
NCT03558919Phase 4Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jan 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron in overactive bladder (OAB), sponsored by Bangabandhu Sheikh Mujib Medical University. Started Jan 2017; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT03558919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03558919.